Chargement en cours...
New perspectives on mTOR inhibitors (rapamycin, rapalogs and TORKinibs) in transplantation
The macrolide rapamycin and its analogues (rapalogs) constitute the first generation of mammalian target of rapamycin (mTOR) inhibitors. Since the introduction of rapamycin as an immunosuppressant, there has been extensive progress in understanding its complex mechanisms of action. New insights into...
Enregistré dans:
| Publié dans: | Br J Clin Pharmacol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5061789/ https://ncbi.nlm.nih.gov/pubmed/26810941 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12893 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|